Results
1 -
8 of
8
(Click
here to explore results)
Cardiovascular and Metabolic Disease: Scientific Discoveries and New Therapies, Chapter 6 New Drug Design and Therapeutic Development for Weight Reduction: Preclinical Studies and Clinical Trials . Steven P. Vickers, Helen C. Jackson, Sharon C. Cheetham
, 2015
, Pages 90-116
New Horizons in Predictive Drug Metabolism and Pharmacokinetics, CHAPTER 5 Non-Cytochrome P450 Enzymes and Glucuronidation . J. Matthew Hutzler, Michael A. Zientek
, 2016
, Pages 79-130
Metabolism, Pharmacokinetics and Toxicity of Functional Groups: Impact of Chemical Building Blocks on ADMET, Chapter 7 Influence of Heteroaromatic Rings on ADME Properties of Drugs . Deepak Dalvie, Ping Kang, Cho-Ming Loi, Lance Goulet, Sajiv Nair
, 2010
, Pages 328-369
Cardiovascular and Metabolic Disease: Scientific Discoveries and New Therapies, Subject Index
, 2015
, Pages 366-376
Drug Repurposing, Chapter 13 Intellectual Property Considerations . Hermann Mucke
, 2022
, Pages 264-279
Metabolism, Pharmacokinetics and Toxicity of Functional Groups: Impact of Chemical Building Blocks on ADMET, Chapter 5 Sulfonamide as an Essential Functional Group in Drug Design . Amit S. Kalgutkar, Rhys Jones, Aarti Sawant
, 2010
, Pages 210-274
Mass Spectrometry: Volume 10, The use of mass spectrometry in studies of drug metabolism and pharmacokinetics . M. E. Rose, D. J. Harvey
, 1989
, Volume 10
, Pages 273-322
Biotransformations: A Survey of the Biotransformations of Drugs and Chemicals in Animals, Compound index . D. R. Hawkins
, 1996
, Volume 7
, Pages 438-456